blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Navigating rare disease patient recruitment

Rare diseases may impact a small portion of the population, yet their significance is profound. And while rare disease patient recruitment might seem similar to...
Continue reading

Clinical trial enrollment planning: The impact of genetics in precision medicine

Genetics has become a defining factor in how clinical trials are designed, who qualifies, and how enrollment is planned. Genetic variation influences both disea...
Continue reading

Patient engagement in precision trials: Recruitment and retention

Clinical trials depend on sustained patient participation, yet recruitment shortfalls and early withdrawals remain two of the most common causes of trial delays...
Continue reading

Clinical trial diversity: Practical steps to improve

Clinical trial populations consistently fail to reflect the demographics of the populations most affected by the diseases being studied. This gap is not simply ...
Continue reading

Why your patient recruitment strategy should include EMR retrieval

In genetically stratified trials, patient recruitment is structurally harder than in conventional studies. Eligibility depends not just on clinical diagnosis, b...
Continue reading

Clinical trial recruitment: EU vs US trial process

Running clinical trials across the European Union (EU) and the United States (US) means operating within two fundamentally different systems. Regulatory framewo...
Continue reading

How to select the right patient registry for your clinical trial

Patient registries, sometimes called patient databases, are a useful tool in any clinical trial patient recruitment strategy. They help researchers identify pot...
Continue reading

Clinical trial recruitment: Parkinson’s channel mix

Clinical trials play a critical role in developing new treatments and therapies for Parkinson's disease, an age-related degenerative brain condition that causes...
Continue reading

Sano x Benevolent AI: Combining machine learning with medical data

Over the past year, Sano and BenevolentAI have collaborated to demonstrate how an integrated, decentralized platform — combining patient recruitment, at-home ge...
Continue reading

Webinar recap: How can applying a "rare disease mindset" accelerate and de-risk precision medicine trials?

In a this webinar, Patrick Short, CEO and co-founder of Sano Genetics, and Patti Engel, CEO of Engage Health, discussed how applying a “rare disease mindset” ca...
Continue reading